Rua Bioscience Limited (NZE:RUA)
0.0280
0.00 (0.00%)
At close: Dec 5, 2025
Rua Bioscience Balance Sheet
Financials in millions NZD. Fiscal year is July - June.
Millions NZD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2019 - 2020 |
| Cash & Equivalents | 0.24 | 0.9 | 2.53 | 1.9 | 3.36 | Upgrade
|
| Short-Term Investments | - | - | 2.03 | 8.04 | 13.04 | Upgrade
|
| Cash & Short-Term Investments | 0.24 | 0.9 | 4.56 | 9.94 | 16.4 | Upgrade
|
| Cash Growth | -73.03% | -80.38% | -54.11% | -39.40% | 316.53% | Upgrade
|
| Accounts Receivable | 0.21 | 0.03 | 0.1 | - | - | Upgrade
|
| Other Receivables | 0.15 | 0.24 | 0.68 | 0.54 | 0.6 | Upgrade
|
| Receivables | 0.37 | 0.26 | 0.78 | 0.54 | 0.6 | Upgrade
|
| Inventory | 0.75 | 0.61 | 0.12 | 0.22 | - | Upgrade
|
| Prepaid Expenses | 0.06 | 0.15 | 0.06 | 0.17 | 0.11 | Upgrade
|
| Restricted Cash | - | - | - | 0.5 | - | Upgrade
|
| Other Current Assets | 0.89 | 0.89 | 0.09 | 0.03 | 0 | Upgrade
|
| Total Current Assets | 2.31 | 2.82 | 5.6 | 11.39 | 17.12 | Upgrade
|
| Property, Plant & Equipment | 2.21 | 2.65 | 4.54 | 6.64 | 7.1 | Upgrade
|
| Goodwill | 2.19 | 2.19 | 10.45 | 10.45 | 4 | Upgrade
|
| Other Intangible Assets | - | - | 0.29 | 5.02 | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 2.55 | Upgrade
|
| Other Long-Term Assets | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Total Assets | 6.78 | 7.74 | 20.95 | 33.57 | 30.85 | Upgrade
|
| Accounts Payable | 0.69 | 0.42 | 0.28 | 0.32 | 0.45 | Upgrade
|
| Accrued Expenses | 0.32 | 0.31 | 0.24 | 0.46 | 0.52 | Upgrade
|
| Short-Term Debt | 0.73 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.01 | Upgrade
|
| Current Portion of Leases | 0.04 | 0.05 | 0.05 | 0.13 | 0.13 | Upgrade
|
| Current Unearned Revenue | - | 0.07 | 0.01 | 0.01 | - | Upgrade
|
| Other Current Liabilities | 0.08 | 0.03 | 0.18 | 3.94 | 0.06 | Upgrade
|
| Total Current Liabilities | 1.85 | 0.87 | 0.76 | 4.86 | 1.18 | Upgrade
|
| Long-Term Leases | 0.04 | 0.1 | 0.07 | 0.7 | 0.81 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 3.82 | 0.03 | Upgrade
|
| Total Liabilities | 1.89 | 0.97 | 0.83 | 9.38 | 2.02 | Upgrade
|
| Common Stock | 45.45 | 43.95 | 43.7 | 41.89 | 37.42 | Upgrade
|
| Retained Earnings | -40.97 | -37.51 | -23.79 | -17.84 | -9.2 | Upgrade
|
| Comprehensive Income & Other | 0.41 | 0.33 | 0.21 | 0.14 | 0.61 | Upgrade
|
| Shareholders' Equity | 4.89 | 6.77 | 20.12 | 24.2 | 28.83 | Upgrade
|
| Total Liabilities & Equity | 6.78 | 7.74 | 20.95 | 33.57 | 30.85 | Upgrade
|
| Total Debt | 0.8 | 0.15 | 0.11 | 0.82 | 0.95 | Upgrade
|
| Net Cash (Debt) | -0.56 | 0.75 | 4.45 | 9.11 | 15.45 | Upgrade
|
| Net Cash Growth | - | -83.19% | -51.21% | -40.99% | 330.41% | Upgrade
|
| Net Cash Per Share | -0.00 | 0.00 | 0.03 | 0.06 | 0.12 | Upgrade
|
| Filing Date Shares Outstanding | 223.65 | 159.75 | 158.14 | 149.88 | 140.26 | Upgrade
|
| Total Common Shares Outstanding | 223.65 | 159.75 | 158.14 | 149.88 | 140.26 | Upgrade
|
| Working Capital | 0.45 | 1.94 | 4.84 | 6.54 | 15.94 | Upgrade
|
| Book Value Per Share | 0.02 | 0.04 | 0.13 | 0.16 | 0.21 | Upgrade
|
| Tangible Book Value | 2.7 | 4.57 | 9.39 | 8.73 | 24.83 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.03 | 0.06 | 0.06 | 0.18 | Upgrade
|
| Buildings | 2.94 | 2.96 | 4.34 | 4.82 | 4.72 | Upgrade
|
| Machinery | 1.28 | 1.58 | 1.85 | 2.27 | 1.88 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.